Physician profile
Raymond Gardner
NPI 1932107489
$6,730.60
in general payments reported to CMS, 2019-2025
45 companies · $1,061 in 2025
The $1,061 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $567 · 2021: $765 · 2022: $983 · 2023: $1,136 · 2024: $1,277 · 2025: $1,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,474.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,125.07 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $879.65 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $599.74 | 2019-2025 | |
| Novo Nordisk INC | $446.40 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $347.72 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Glaxosmithkline, LLC. | $322.24 | 2020-2025 | Bexsero, Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $226.50 | 2021-2025 | Spravato |
| Sanofi-Aventis U.S. LLC | $209.34 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $205.47 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $172.61 | 2019-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $158.96 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $149.83 | 2022-2025 | Strensiq |
| Astellas Pharma US INC | $147.61 | 2019-2024 | Veozah, Myrbetriq |
| Abbott Laboratories | $136.55 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $134.24 | 2019-2024 | Repatha, Otezla, Evenity |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.